These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9414118

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family.
    Grunberg J, Walter J, Loetscher H, Deuschle U, Jacobsen H, Haass C.
    Biochemistry; 1998 Feb 24; 37(8):2263-70. PubMed ID: 9485372
    [Abstract] [Full Text] [Related]

  • 4. Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.
    Murayama O, Honda T, Mercken M, Murayama M, Yasutake K, Nihonmatsu N, Nakazato Y, Michel G, Song S, Sato K, Takahashi H, Takashima A.
    Neurosci Lett; 1997 Jun 20; 229(1):61-4. PubMed ID: 9224802
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impaired proteolytic processing of presenilin-1 in chromosome 14-linked familial Alzheimer's disease patient lymphocytes.
    Takahashi H, Mercken M, Honda T, Saito Y, Murayama M, Song S, Takashima A.
    Neurosci Lett; 1999 Jan 29; 260(2):121-4. PubMed ID: 10025714
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
    Walker ES, Martinez M, Brunkan AL, Goate A.
    J Neurochem; 2005 Jan 29; 92(2):294-301. PubMed ID: 15663477
    [Abstract] [Full Text] [Related]

  • 16. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing.
    Mercken M, Takahashi H, Honda T, Sato K, Murayama M, Nakazato Y, Noguchi K, Imahori K, Takashima A.
    FEBS Lett; 1996 Jul 08; 389(3):297-303. PubMed ID: 8766720
    [Abstract] [Full Text] [Related]

  • 17. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
    Mathews PM, Cataldo AM, Kao BH, Rudnicki AG, Qin X, Yang JL, Jiang Y, Picciano M, Hulette C, Lippa CF, Bird TD, Nochlin D, Walter J, Haass C, Lévesque L, Fraser PE, Andreadis A, Nixon RA.
    Mol Med; 2000 Oct 08; 6(10):878-91. PubMed ID: 11126202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains.
    Tomidokoro Y, Ishiguro K, Igeta Y, Matsubara E, Kanai M, Shizuka M, Kawarabayashi T, Harigaya Y, Kawakatsu S, Ii K, Ikeda M, St George-Hyslop PH, Hirai S, Okamoto K, Shoji M.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):512-8. PubMed ID: 10080929
    [Abstract] [Full Text] [Related]

  • 20. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo.
    Lee MK, Borchelt DR, Kim G, Thinakaran G, Slunt HH, Ratovitski T, Martin LJ, Kittur A, Gandy S, Levey AI, Jenkins N, Copeland N, Price DL, Sisodia SS.
    Nat Med; 1997 Jul 24; 3(7):756-60. PubMed ID: 9212102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.